{"gene":"VPS53","run_date":"2026-06-11T09:02:06","timeline":{"discoveries":[{"year":2010,"finding":"Crystal structure of the C-terminal fragment of Vps53 (at 2.9 Å resolution) revealed two alpha-helical bundles arranged in tandem with a highly conserved surface patch. Mutagenesis of this surface patch caused defects in membrane traffic, identifying this region as functionally critical for vesicle recognition in endosome-to-TGN retrograde transport.","method":"X-ray crystallography (2.9 Å) combined with site-directed mutagenesis and membrane traffic functional assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure at defined resolution with functional mutagenesis validation in a single rigorous study","pmids":["20660722"],"is_preprint":false},{"year":2010,"finding":"The fold of the Vps53 C-terminal domain is structurally reminiscent of subunits from three other tethering complexes (Dsl1, conserved oligomeric Golgi, and the exocyst), indicating that GARP belongs to the same evolutionary family of membrane-tethering complexes.","method":"Structural comparison via X-ray crystallography","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Moderate — structure-based finding with clear domain-fold comparison, single rigorous study","pmids":["20660722"],"is_preprint":false},{"year":2014,"finding":"Loss-of-function compound heterozygous mutations in VPS53 (c.2084A>G and c.1556+5G>A) affecting its C-terminal domain cause abnormal accumulation of swollen CD63-positive vesicular bodies (likely intermediate recycling/late endosomes) in patient fibroblasts, establishing VPS53 as essential for retrograde endosome-to-Golgi vesicle recycling in human cells.","method":"Immunofluorescence microscopy of patient fibroblasts with CD63 marker; whole exome sequencing and linkage analysis","journal":"Journal of medical genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization experiment with functional consequence in patient cells, supported by genetic identification, single lab","pmids":["24577744"],"is_preprint":false},{"year":2014,"finding":"VPS53 functions as a subunit of the Golgi-associated retrograde protein (GARP) complex, which mediates retrograde transport of endocytic vesicles to the trans-Golgi network; the C-terminal domain of VPS53 is critical for this function.","method":"Genetic mapping, whole exome sequencing, and immunofluorescence microscopy in patient-derived fibroblasts","journal":"Journal of medical genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic and cell biology evidence from patient fibroblasts, consistent with yeast structural data, single lab","pmids":["24577744"],"is_preprint":false},{"year":2019,"finding":"A homozygous VPS53 missense variant (c.2084A>G, p.Gln695Arg) was identified as causative in complicated hereditary spastic paraparesis, placing VPS53/GARP function in intracellular cholesterol transport and sphingolipid homeostasis in lysosomes as relevant to neurodegeneration.","method":"Whole exome sequencing with family-based genetic analysis","journal":"Neurogenetics","confidence":"Low","confidence_rationale":"Tier 3 / Weak — genetic identification only, no direct biochemical functional assay performed in this study","pmids":["31418091"],"is_preprint":false},{"year":2020,"finding":"Overexpression of VPS53 in colorectal cancer cells upregulated Beclin 1 and LC3B-II and induced autophagy; pharmacological inhibition of autophagy attenuated the VPS53-mediated suppression of cancer cell proliferation, migration, and invasion, placing VPS53 upstream of the autophagy pathway in CRC cells.","method":"Overexpression with CCK-8, flow cytometry, transwell assay, electron microscopy, and Western blotting; autophagy inhibitor rescue experiment","journal":"OncoTargets and therapy","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, functional overexpression with pathway markers and inhibitor rescue, but no direct mechanistic link between GARP function and autophagy established","pmids":["33116643"],"is_preprint":false},{"year":2018,"finding":"Treatment with GZFLW increased VPS53 protein stability (not mRNA level) in endometrial stromal cells, suggesting VPS53 is subject to post-translational regulation of protein stability, and elevated VPS53 promoted apoptosis in these cells.","method":"iTRAQ proteomics, LC-MS/MS, and Western blotting in human endometrial stromal cells","journal":"Evidence-based complementary and alternative medicine : eCAM","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, proteomics identification with Western blot confirmation; mechanism of stabilization not elucidated","pmids":["30643524"],"is_preprint":false}],"current_model":"VPS53 is a subunit of the Golgi-associated retrograde protein (GARP) tethering complex whose C-terminal domain (structurally related to Dsl1, COG, and exocyst complex subunits) contains a conserved surface patch required for recognition and tethering of endosome-derived vesicles to the trans-Golgi network; loss of VPS53 function disrupts this retrograde trafficking pathway, causing accumulation of aberrant late endosomal/recycling vesicles, and in humans leads to progressive neurological disease."},"narrative":{"mechanistic_narrative":"VPS53 is a subunit of the Golgi-associated retrograde protein (GARP) tethering complex that mediates retrograde transport of endosome-derived vesicles to the trans-Golgi network [PMID:24577744]. Its C-terminal domain adopts two tandem alpha-helical bundles bearing a conserved surface patch; mutagenesis of this patch disrupts membrane traffic, identifying the region as the functional element for vesicle recognition in endosome-to-TGN retrograde transport [PMID:20660722]. This fold is shared with subunits of the Dsl1, COG, and exocyst tethering complexes, placing GARP within a common evolutionary family of membrane-tethering machines [PMID:20660722]. In human cells, loss-of-function mutations affecting the VPS53 C-terminal domain cause accumulation of swollen CD63-positive vesicular bodies, confirming that VPS53 is required for retrograde endosome-to-Golgi recycling [PMID:24577744]. Biallelic VPS53 mutations cause progressive neurological disease, including complicated hereditary spastic paraparesis [PMID:24577744, PMID:31418091].","teleology":[{"year":2010,"claim":"Established the structural basis for how VPS53 contributes to vesicle tethering, answering which part of the protein performs the recognition function and revealing its evolutionary relationship to other tethering complexes.","evidence":"X-ray crystallography of the Vps53 C-terminal fragment at 2.9 Å with site-directed mutagenesis and membrane traffic assay","pmids":["20660722"],"confidence":"High","gaps":["Structure covers only the C-terminal fragment, not the full GARP assembly","Identity of the recognized vesicle component/SNARE not resolved","How the conserved patch engages incoming vesicles mechanistically not shown"]},{"year":2014,"claim":"Connected VPS53 GARP function to human cell biology and disease, showing that C-terminal mutations disrupt retrograde recycling and produce a measurable endosomal phenotype in patient cells.","evidence":"Whole exome sequencing, linkage analysis, and CD63 immunofluorescence in patient-derived fibroblasts","pmids":["24577744"],"confidence":"Medium","gaps":["Cargo whose missorting drives the cellular phenotype not identified","Single-lab patient-cell observation without biochemical reconstitution","Link between vesicle accumulation and neurological pathology not mechanistically traced"]},{"year":2019,"claim":"Extended the genetic spectrum by linking a homozygous VPS53 missense variant to complicated hereditary spastic paraparesis, framing GARP dysfunction in a lysosomal lipid-homeostasis context.","evidence":"Whole exome sequencing with family-based genetic analysis","pmids":["31418091"],"confidence":"Low","gaps":["Genetic identification only; no biochemical functional assay performed","Proposed role in cholesterol/sphingolipid transport not directly tested for this variant","Causal mechanism linking variant to neurodegeneration unestablished"]},{"year":2020,"claim":"Raised a possible role for VPS53 upstream of autophagy in cancer cells, distinct from its canonical trafficking function.","evidence":"Overexpression in colorectal cancer cells with autophagy marker Western blotting, proliferation/migration/invasion assays, and autophagy inhibitor rescue","pmids":["33116643"],"confidence":"Low","gaps":["No mechanistic link between GARP/retrograde function and autophagy induction established","Overexpression-based; physiological relevance unclear","Single-lab finding without independent confirmation"]},{"year":2018,"claim":"Indicated that VPS53 abundance is controlled post-translationally, hinting at regulation of the protein independent of transcription.","evidence":"iTRAQ proteomics, LC-MS/MS, and Western blotting in human endometrial stromal cells","pmids":["30643524"],"confidence":"Low","gaps":["Mechanism of protein stabilization not elucidated","Single-lab proteomic observation","Functional consequence for GARP trafficking not assessed"]},{"year":null,"claim":"The specific vesicular cargo recognized by the VPS53 conserved surface patch and how GARP-dependent retrograde defects translate into neurodegeneration remain undefined.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No identified cargo or SNARE partner for the tethering reaction","No full-length GARP complex structure","Causal chain from trafficking defect to neuronal pathology not mapped"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[0,1,3]}],"localization":[{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[0,3]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[2,3]}],"pathway":[{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[0,2,3]}],"complexes":["GARP complex"],"partners":[],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q5VIR6","full_name":"Vacuolar protein sorting-associated protein 53 homolog","aliases":[],"length_aa":832,"mass_kda":94.4,"function":"Acts as a component of the GARP complex that is involved in retrograde transport from early and late endosomes to the trans-Golgi network (TGN). The GARP complex is required for the maintenance of the cycling of mannose 6-phosphate receptors between the TGN and endosomes, this cycling is necessary for proper lysosomal sorting of acid hydrolases such as CTSD (PubMed:15878329, PubMed:18367545). Acts as a component of the EARP complex that is involved in endocytic recycling. The EARP complex associates with Rab4-positive endosomes and promotes recycling of internalized transferrin receptor (TFRC) to the plasma membrane (PubMed:25799061)","subcellular_location":"Golgi apparatus, trans-Golgi network membrane; Endosome membrane; Recycling endosome","url":"https://www.uniprot.org/uniprotkb/Q5VIR6/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/VPS53","classification":"Not Classified","n_dependent_lines":224,"n_total_lines":1208,"dependency_fraction":0.18543046357615894},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/VPS53","total_profiled":1310},"omim":[{"mim_id":"616465","title":"VPS50, EARP/GARPII COMPLEX SUBUNIT; VPS50","url":"https://www.omim.org/entry/616465"},{"mim_id":"615851","title":"PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E","url":"https://www.omim.org/entry/615851"},{"mim_id":"615850","title":"VPS53 SUBUNIT OF GARP COMPLEX; VPS53","url":"https://www.omim.org/entry/615850"},{"mim_id":"615738","title":"VPS51 SUBUNIT OF GARP COMPLEX; VPS51","url":"https://www.omim.org/entry/615738"},{"mim_id":"614633","title":"VPS54 SUBUNIT OF GARP COMPLEX; VPS54","url":"https://www.omim.org/entry/614633"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Golgi apparatus","reliability":"Supported"},{"location":"Vesicles","reliability":"Supported"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/VPS53"},"hgnc":{"alias_symbol":["FLJ10979","HCCS1"],"prev_symbol":[]},"alphafold":{"accession":"Q5VIR6","domains":[{"cath_id":"-","chopping":"8-131","consensus_level":"medium","plddt":75.5533,"start":8,"end":131},{"cath_id":"-","chopping":"166-226_234-362","consensus_level":"medium","plddt":90.1368,"start":166,"end":362},{"cath_id":"1.10.357.50","chopping":"423-519_544-599","consensus_level":"medium","plddt":88.8027,"start":423,"end":599},{"cath_id":"-","chopping":"746-794","consensus_level":"medium","plddt":84.5782,"start":746,"end":794}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q5VIR6","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q5VIR6-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q5VIR6-F1-predicted_aligned_error_v6.png","plddt_mean":80.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=VPS53","jax_strain_url":"https://www.jax.org/strain/search?query=VPS53"},"sequence":{"accession":"Q5VIR6","fasta_url":"https://rest.uniprot.org/uniprotkb/Q5VIR6.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q5VIR6/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q5VIR6"}},"corpus_meta":[{"pmid":"24577744","id":"PMC_24577744","title":"VPS53 mutations cause progressive cerebello-cerebral atrophy type 2 (PCCA2).","date":"2014","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24577744","citation_count":72,"is_preprint":false},{"pmid":"20660722","id":"PMC_20660722","title":"Structure of a C-terminal fragment of its Vps53 subunit suggests similarity of Golgi-associated retrograde protein (GARP) complex to a family of tethering complexes.","date":"2010","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/20660722","citation_count":33,"is_preprint":false},{"pmid":"17666431","id":"PMC_17666431","title":"The tail-anchoring domain of Bfl1 and HCCS1 targets mitochondrial membrane permeability to induce apoptosis.","date":"2007","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/17666431","citation_count":25,"is_preprint":false},{"pmid":"22040050","id":"PMC_22040050","title":"HCCS1-armed, quadruple-regulated oncolytic adenovirus specific for liver cancer as a cancer targeting gene-viro-therapy strategy.","date":"2011","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/22040050","citation_count":23,"is_preprint":false},{"pmid":"18511934","id":"PMC_18511934","title":"HCCS1 overexpression induces apoptosis via cathepsin D and intracellular calcium, and HCCS1 disruption in mice causes placental abnormality.","date":"2008","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/18511934","citation_count":17,"is_preprint":false},{"pmid":"11857354","id":"PMC_11857354","title":"Candidate tumor suppressor, HCCS-1, is downregulated in human cancers and induces apoptosis in cervical cancer.","date":"2002","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/11857354","citation_count":17,"is_preprint":false},{"pmid":"31418091","id":"PMC_31418091","title":"VPS53 gene is associated with a new phenotype of complicated hereditary spastic paraparesis.","date":"2019","source":"Neurogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/31418091","citation_count":14,"is_preprint":false},{"pmid":"18617915","id":"PMC_18617915","title":"Adenovirus-mediated HCCS1 overexpression elicits a potent antitumor efficacy on human colorectal cancer and hepatoma cells both in vitro and in vivo.","date":"2008","source":"Cancer gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/18617915","citation_count":12,"is_preprint":false},{"pmid":"33116643","id":"PMC_33116643","title":"VPS53 Suppresses Malignant Properties in Colorectal Cancer by Inducing the Autophagy Signaling Pathway.","date":"2020","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/33116643","citation_count":8,"is_preprint":false},{"pmid":"26782579","id":"PMC_26782579","title":"Characterization and functional analysis of a chitin synthase gene (HcCS1) identified from the freshwater pearlmussel Hyriopsis cumingii.","date":"2015","source":"Genetics and molecular research : GMR","url":"https://pubmed.ncbi.nlm.nih.gov/26782579","citation_count":6,"is_preprint":false},{"pmid":"12780520","id":"PMC_12780520","title":"Genetic alterations of the HCCS1 gene in Korean hepatocellular carcinoma.","date":"2003","source":"APMIS : acta pathologica, microbiologica, et immunologica Scandinavica","url":"https://pubmed.ncbi.nlm.nih.gov/12780520","citation_count":5,"is_preprint":false},{"pmid":"18949398","id":"PMC_18949398","title":"Potent anti-hepatoma efficacy of HCCS1 via dual tumor-targeting gene-virotherapy strategy.","date":"2008","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/18949398","citation_count":5,"is_preprint":false},{"pmid":"16953216","id":"PMC_16953216","title":"Transcription of the putative tumor suppressor gene HCCS1 requires binding of ETS-2 to its consensus near the transcription start site.","date":"2006","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/16953216","citation_count":5,"is_preprint":false},{"pmid":"30643524","id":"PMC_30643524","title":"GZFLW Induces Apoptosis of Ectopic Endometrial Stromal Cells via Promoting VPS53 Protein Stability.","date":"2018","source":"Evidence-based complementary and alternative medicine : eCAM","url":"https://pubmed.ncbi.nlm.nih.gov/30643524","citation_count":2,"is_preprint":false},{"pmid":"23788903","id":"PMC_23788903","title":"Expression and clinical significance of HCCS1 in non-small cell lung cancer.","date":"2012","source":"Contemporary oncology (Poznan, Poland)","url":"https://pubmed.ncbi.nlm.nih.gov/23788903","citation_count":0,"is_preprint":false},{"pmid":"18510848","id":"PMC_18510848","title":"[Tumor-targeting expression of a new tumor suppressor gene HCCS1 and its tumor-selective inhibitory effects on hepatocellular carcinoma].","date":"2008","source":"Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/18510848","citation_count":0,"is_preprint":false},{"pmid":"30915757","id":"PMC_30915757","title":"HCCS1 inhibits the stemness of human pancreatic cancer stem-like cells.","date":"2019","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30915757","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":10073,"output_tokens":2081,"usd":0.030717,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":8463,"output_tokens":2028,"usd":0.046508,"stage2_stop_reason":"end_turn"},"total_usd":0.077225,"stage1_batch_id":"msgbatch_01UT1AahFPCAyn2uVweS7A9z","stage2_batch_id":"msgbatch_01HuKWtKNT4Pqj1bc8eEP5RV","note":"batch pricing = 50% of standard"},"stage1_raw":"I need to carefully classify each paper before extracting discoveries.\n\n**Classification analysis:**\n\n- Papers [1], [2], [7], [9], [14]: About VPS53 (the canonical GARP complex subunit) — INCLUDE\n- Papers [3], [4], [5], [6], [8], [12], [13], [15], [16], [17]: About HCCS1 — need to determine if this is the same gene as VPS53. The HGNC aliases list \"HCCS1\" as an alias for VPS53. However, examining these papers: they describe HCCS1 as a Bcl2-family-related protein targeting mitochondria (paper [3]), inducing apoptosis via cathepsin D/calcium/cytochrome c (paper [5]), a tumor suppressor with mitochondrial targeting domain. Paper [7] explicitly states VPS53 \"was previously associated with progressive cerebello-cerebral atrophy (PCCA) type 2\" — consistent with paper [1]. The HCCS1 in papers [3]-[6] describes a protein with mitochondrial targeting, Bcl2-like properties — this does NOT match VPS53/GARP complex function. This appears to be an alias collision: \"HCCS1\" (hepatocellular carcinoma suppressor 1) is a different gene from VPS53. Despite the HGNC alias listing, the biology is fundamentally incompatible. I will exclude papers [3]-[6], [8], [11]-[13], [15]-[17] as alias collisions.\n\n- Paper [10]: Chitin synthase in mussel — EXCLUDE (symbol collision)\n- Paper [11]: HCCS1 mutations in HCC — EXCLUDE (alias collision)\n\n**Included papers:** [1], [2], [7], [9], [14]\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2010,\n      \"finding\": \"Crystal structure of the C-terminal fragment of Vps53 (at 2.9 Å resolution) revealed two alpha-helical bundles arranged in tandem with a highly conserved surface patch. Mutagenesis of this surface patch caused defects in membrane traffic, identifying this region as functionally critical for vesicle recognition in endosome-to-TGN retrograde transport.\",\n      \"method\": \"X-ray crystallography (2.9 Å) combined with site-directed mutagenesis and membrane traffic functional assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure at defined resolution with functional mutagenesis validation in a single rigorous study\",\n      \"pmids\": [\"20660722\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The fold of the Vps53 C-terminal domain is structurally reminiscent of subunits from three other tethering complexes (Dsl1, conserved oligomeric Golgi, and the exocyst), indicating that GARP belongs to the same evolutionary family of membrane-tethering complexes.\",\n      \"method\": \"Structural comparison via X-ray crystallography\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — structure-based finding with clear domain-fold comparison, single rigorous study\",\n      \"pmids\": [\"20660722\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Loss-of-function compound heterozygous mutations in VPS53 (c.2084A>G and c.1556+5G>A) affecting its C-terminal domain cause abnormal accumulation of swollen CD63-positive vesicular bodies (likely intermediate recycling/late endosomes) in patient fibroblasts, establishing VPS53 as essential for retrograde endosome-to-Golgi vesicle recycling in human cells.\",\n      \"method\": \"Immunofluorescence microscopy of patient fibroblasts with CD63 marker; whole exome sequencing and linkage analysis\",\n      \"journal\": \"Journal of medical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization experiment with functional consequence in patient cells, supported by genetic identification, single lab\",\n      \"pmids\": [\"24577744\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"VPS53 functions as a subunit of the Golgi-associated retrograde protein (GARP) complex, which mediates retrograde transport of endocytic vesicles to the trans-Golgi network; the C-terminal domain of VPS53 is critical for this function.\",\n      \"method\": \"Genetic mapping, whole exome sequencing, and immunofluorescence microscopy in patient-derived fibroblasts\",\n      \"journal\": \"Journal of medical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic and cell biology evidence from patient fibroblasts, consistent with yeast structural data, single lab\",\n      \"pmids\": [\"24577744\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"A homozygous VPS53 missense variant (c.2084A>G, p.Gln695Arg) was identified as causative in complicated hereditary spastic paraparesis, placing VPS53/GARP function in intracellular cholesterol transport and sphingolipid homeostasis in lysosomes as relevant to neurodegeneration.\",\n      \"method\": \"Whole exome sequencing with family-based genetic analysis\",\n      \"journal\": \"Neurogenetics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — genetic identification only, no direct biochemical functional assay performed in this study\",\n      \"pmids\": [\"31418091\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Overexpression of VPS53 in colorectal cancer cells upregulated Beclin 1 and LC3B-II and induced autophagy; pharmacological inhibition of autophagy attenuated the VPS53-mediated suppression of cancer cell proliferation, migration, and invasion, placing VPS53 upstream of the autophagy pathway in CRC cells.\",\n      \"method\": \"Overexpression with CCK-8, flow cytometry, transwell assay, electron microscopy, and Western blotting; autophagy inhibitor rescue experiment\",\n      \"journal\": \"OncoTargets and therapy\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, functional overexpression with pathway markers and inhibitor rescue, but no direct mechanistic link between GARP function and autophagy established\",\n      \"pmids\": [\"33116643\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Treatment with GZFLW increased VPS53 protein stability (not mRNA level) in endometrial stromal cells, suggesting VPS53 is subject to post-translational regulation of protein stability, and elevated VPS53 promoted apoptosis in these cells.\",\n      \"method\": \"iTRAQ proteomics, LC-MS/MS, and Western blotting in human endometrial stromal cells\",\n      \"journal\": \"Evidence-based complementary and alternative medicine : eCAM\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, proteomics identification with Western blot confirmation; mechanism of stabilization not elucidated\",\n      \"pmids\": [\"30643524\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"VPS53 is a subunit of the Golgi-associated retrograde protein (GARP) tethering complex whose C-terminal domain (structurally related to Dsl1, COG, and exocyst complex subunits) contains a conserved surface patch required for recognition and tethering of endosome-derived vesicles to the trans-Golgi network; loss of VPS53 function disrupts this retrograde trafficking pathway, causing accumulation of aberrant late endosomal/recycling vesicles, and in humans leads to progressive neurological disease.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"VPS53 is a subunit of the Golgi-associated retrograde protein (GARP) tethering complex that mediates retrograde transport of endosome-derived vesicles to the trans-Golgi network [#3]. Its C-terminal domain adopts two tandem alpha-helical bundles bearing a conserved surface patch; mutagenesis of this patch disrupts membrane traffic, identifying the region as the functional element for vesicle recognition in endosome-to-TGN retrograde transport [#0]. This fold is shared with subunits of the Dsl1, COG, and exocyst tethering complexes, placing GARP within a common evolutionary family of membrane-tethering machines [#1]. In human cells, loss-of-function mutations affecting the VPS53 C-terminal domain cause accumulation of swollen CD63-positive vesicular bodies, confirming that VPS53 is required for retrograde endosome-to-Golgi recycling [#2]. Biallelic VPS53 mutations cause progressive neurological disease, including complicated hereditary spastic paraparesis [#2, #4].\",\n  \"teleology\": [\n    {\n      \"year\": 2010,\n      \"claim\": \"Established the structural basis for how VPS53 contributes to vesicle tethering, answering which part of the protein performs the recognition function and revealing its evolutionary relationship to other tethering complexes.\",\n      \"evidence\": \"X-ray crystallography of the Vps53 C-terminal fragment at 2.9 Å with site-directed mutagenesis and membrane traffic assay\",\n      \"pmids\": [\"20660722\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structure covers only the C-terminal fragment, not the full GARP assembly\",\n        \"Identity of the recognized vesicle component/SNARE not resolved\",\n        \"How the conserved patch engages incoming vesicles mechanistically not shown\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Connected VPS53 GARP function to human cell biology and disease, showing that C-terminal mutations disrupt retrograde recycling and produce a measurable endosomal phenotype in patient cells.\",\n      \"evidence\": \"Whole exome sequencing, linkage analysis, and CD63 immunofluorescence in patient-derived fibroblasts\",\n      \"pmids\": [\"24577744\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Cargo whose missorting drives the cellular phenotype not identified\",\n        \"Single-lab patient-cell observation without biochemical reconstitution\",\n        \"Link between vesicle accumulation and neurological pathology not mechanistically traced\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Extended the genetic spectrum by linking a homozygous VPS53 missense variant to complicated hereditary spastic paraparesis, framing GARP dysfunction in a lysosomal lipid-homeostasis context.\",\n      \"evidence\": \"Whole exome sequencing with family-based genetic analysis\",\n      \"pmids\": [\"31418091\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"Genetic identification only; no biochemical functional assay performed\",\n        \"Proposed role in cholesterol/sphingolipid transport not directly tested for this variant\",\n        \"Causal mechanism linking variant to neurodegeneration unestablished\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Raised a possible role for VPS53 upstream of autophagy in cancer cells, distinct from its canonical trafficking function.\",\n      \"evidence\": \"Overexpression in colorectal cancer cells with autophagy marker Western blotting, proliferation/migration/invasion assays, and autophagy inhibitor rescue\",\n      \"pmids\": [\"33116643\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No mechanistic link between GARP/retrograde function and autophagy induction established\",\n        \"Overexpression-based; physiological relevance unclear\",\n        \"Single-lab finding without independent confirmation\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Indicated that VPS53 abundance is controlled post-translationally, hinting at regulation of the protein independent of transcription.\",\n      \"evidence\": \"iTRAQ proteomics, LC-MS/MS, and Western blotting in human endometrial stromal cells\",\n      \"pmids\": [\"30643524\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"Mechanism of protein stabilization not elucidated\",\n        \"Single-lab proteomic observation\",\n        \"Functional consequence for GARP trafficking not assessed\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The specific vesicular cargo recognized by the VPS53 conserved surface patch and how GARP-dependent retrograde defects translate into neurodegeneration remain undefined.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No identified cargo or SNARE partner for the tethering reaction\",\n        \"No full-length GARP complex structure\",\n        \"Causal chain from trafficking defect to neuronal pathology not mapped\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0, 1, 3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [0, 3]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [2, 3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [0, 2, 3]}\n    ],\n    \"complexes\": [\"GARP complex\"],\n    \"partners\": [],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}